EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer

Jiasha Wu, Rui Ji, Luyi Wang, Yurui Zhu, Shiqin Jian, Yan Zuo, Siyao Liu, Yejiao Shi, Xiaochun Hu, Honggang Hu

Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7786-7803

DOI: 10.1016/j.apsb.2026.07.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Jiasha Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Sciences, School of Medicine, Shanghai University, Shanghai 200444, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

FerroptosisGPX4Immunogenic cell deathImmunotherapyNano-PROTACPeptidePhotodynamic therapyTriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Chemistry, College of Sciences, School of Medicine, Shanghai University, Shanghai 200444, China.
  • Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.
  • Shanghai Integration and Innovation Center of Marine Medical Engineering, Shanghai Engineering Research Center of Organ Repair, Shanghai University, Shanghai 200444, China.
  • School of Pharmacy, Chengdu Medical College, Chengdu 610083, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, J., Ji, R., Wang, L., Zhu, Y., Jian, S., Zuo, Y., Liu, S., Shi, Y., Hu, X., & Hu, H. (2026). A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer. Acta Pharmaceutica Sinica B, 16(11), 7786-7803. https://doi.org/10.1016/j.apsb.2026.07.045

Vancouver

Wu J, Ji R, Wang L, Zhu Y, Jian S, Zuo Y, et al. A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer. Acta Pharmaceutica Sinica B. 2026;16(11):7786-7803. doi:10.1016/j.apsb.2026.07.045

BibTeX
@article{Wu2026,
  author = {Wu, Jiasha and Ji, Rui and Wang, Luyi and Zhu, Yurui and Jian, Shiqin and Zuo, Yan and Liu, Siyao and Shi, Yejiao and Hu, Xiaochun and Hu, Honggang},
  title = {A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {7786--7803},
  doi = {10.1016/j.apsb.2026.07.045}
}
Kostenlos starten →